Recombinant BMP4 and BMP7 downregulate pentraxin 3 in human granulosa cells

J Clin Endocrinol Metab. 2015 Mar;100(3):E365-74. doi: 10.1210/jc.2014-2496. Epub 2014 Dec 16.

Abstract

Context: Theca cell-derived bone morphogenetic protein 4 (BMP4) and BMP7 are important regulators of folliculogenesis and have been shown to inhibit luteinization. Pentraxin 3 (PTX3) plays a critical role in the assembly of the cumulus oophorus extracellular matrix, which is essential for cumulus expansion during ovulation and may be modulated by BMP4 and BMP7.

Objective: The aim of this study was to investigate the effects of BMP4 and BMP7 on the expression of PTX3 in human granulosa cells and to examine their underlying molecular determinants.

Design: An established immortalized human granulosa cell line (SVOG), a granulosa cell tumor cell line (KGN), and primary granulosa-lutein cells were used as study models. PTX3 expression and accumulation as well as Smad1/5/8 phosphorylation were examined after exposure to recombinant human BMP4 and BMP7. BMP type I receptor involvement was investigated with inhibitors (dorsomorphin and DMH-1 (4-[6-[4-(1-Methylethoxy)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]-quinoline)) and small interfering RNAs targeting activin receptor-like kinase (ALK)2, ALK3, and/or ALK6. Small interfering RNAs targeting Smad4 were used to verify the involvement of Smad signaling.

Setting: The study was conducted at an academic research center.

Main outcome measures: Quantitative RT-PCR and Western blot were used to measure mRNA and protein levels, respectively. Levels of PTX3 and BMP4 were measured by ELISA.

Results: Treatment with BMP4 and BMP7 significantly decreased PTX3 mRNA and protein production. These suppressive effects, along with the induction of Smad1/5/8 phosphorylation, were attenuated by cotreatment with 2 BMP type I receptor inhibitors (dorsomorphin and/or DMH-1). Combined knockdown (ALK3/ALK6 for BMP4 and ALK2/ALK3 for BMP7) reversed the effects of BMP4- and BMP7-induced Smad1/5/8 phosphorylation and PTX3 suppression. Furthermore, Smad4 knockdown reversed the suppressive effects of BMP4 and BMP7 on PTX3 expression. In follicular fluid, concentrations of PTX3 were negatively correlated with concentrations of BMP4.

Conclusion: BMP4 and BMP7 use differential subsets of BMP type I receptors to downregulate PTX3 expression via Smad-dependent signaling in human granulosa cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bone Morphogenetic Protein 4 / pharmacology*
  • Bone Morphogenetic Protein 7 / pharmacology*
  • Bone Morphogenetic Protein Receptors, Type I / physiology
  • C-Reactive Protein / genetics*
  • C-Reactive Protein / metabolism
  • Cells, Cultured
  • Down-Regulation / drug effects
  • Down-Regulation / genetics
  • Female
  • Granulosa Cells / drug effects*
  • Granulosa Cells / metabolism*
  • Humans
  • RNA, Small Interfering / pharmacology
  • Recombinant Proteins / pharmacology
  • Serum Amyloid P-Component / genetics*
  • Serum Amyloid P-Component / metabolism
  • Signal Transduction / drug effects
  • Signal Transduction / genetics
  • Smad Proteins / metabolism

Substances

  • BMP4 protein, human
  • BMP7 protein, human
  • Bone Morphogenetic Protein 4
  • Bone Morphogenetic Protein 7
  • RNA, Small Interfering
  • Recombinant Proteins
  • Serum Amyloid P-Component
  • Smad Proteins
  • PTX3 protein
  • C-Reactive Protein
  • Bone Morphogenetic Protein Receptors, Type I